Afarinkia K - Search Results

1

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens.

Al-Warhi T, Elimam DM, Elsayed ZM, Abdel-Aziz MM, Maklad RM, Al-Karmalawy AA, Afarinkia K, Abourehab MAS, Abdel-Aziz HA, Eldehna WM. Al-Warhi T, et al. Among authors: afarinkia k. RSC Adv. 2022 Nov 2;12(48):31466-31477. doi: 10.1039/d2ra04385h. eCollection 2022 Oct 27. RSC Adv. 2022. PMID: 36382148 Free PMC article.

2

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.

Eldehna WM, Taghour MS, Al-Warhi T, Nocentini A, Elbadawi MM, Mahdy HA, Abdelrahman MA, Alotaibi OJ, Aljaeed N, Elimam DM, Afarinkia K, Abdel-Aziz HA, Supuran CT. Eldehna WM, et al. Among authors: afarinkia k. J Enzyme Inhib Med Chem. 2022 Dec;37(1):531-541. doi: 10.1080/14756366.2021.2024528. J Enzyme Inhib Med Chem. 2022. PMID: 34991416 Free PMC article.

3

Control of the stereochemistry of C14 hydroxyl during the total synthesis of withanolide E and physachenolide C.

Anees M, Nayak S, Afarinkia K, Vinader V. Anees M, et al. Among authors: afarinkia k. RSC Adv. 2018 Nov 27;8(69):39691-39695. doi: 10.1039/c8ra08540d. eCollection 2018 Nov 23. RSC Adv. 2018. PMID: 35558026 Free PMC article.

4

tert-Butyl(2-oxo-2H-pyran-5-yl)carbamate as the First Chameleon Diene Bearing an Electron-Donating Substituent.

Omar YM, Santucci G, Afarinkia K. Omar YM, et al. Among authors: afarinkia k. Molecules. 2022 Sep 2;27(17):5666. doi: 10.3390/molecules27175666. Molecules. 2022. PMID: 36080432 Free PMC article.

5

The emerging role of CXC chemokines and their receptors in cancer.

Vinader V, Afarinkia K. Vinader V, et al. Among authors: afarinkia k. Future Med Chem. 2012 May;4(7):853-67. doi: 10.4155/fmc.12.48. Future Med Chem. 2012. PMID: 22571611 Review.

6

Carbasugar probes to explore the enzyme binding pocket at the anomeric position: application to the design of Golgi mannosidase II inhibitors.

Vinader MV, Afarinkia K. Vinader MV, et al. Among authors: afarinkia k. Curr Med Chem. 2013;20(30):3797-801. doi: 10.2174/09298673113209990180. Curr Med Chem. 2013. PMID: 23848537

7

Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.

Vinader V, Ahmet DS, Ahmed MS, Patterson LH, Afarinkia K. Vinader V, et al. Among authors: afarinkia k. PLoS One. 2013 Oct 18;8(10):e78744. doi: 10.1371/journal.pone.0078744. eCollection 2013. PLoS One. 2013. PMID: 24205302 Free PMC article.

8

CCR7 as a therapeutic target in Cancer.

Salem A, Alotaibi M, Mroueh R, Basheer HA, Afarinkia K. Salem A, et al. Among authors: afarinkia k. Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188499. doi: 10.1016/j.bbcan.2020.188499. Epub 2020 Dec 29. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33385485 Review.

9

A beginner's guide to chemokines.

Vinader V, Afarinkia K. Vinader V, et al. Among authors: afarinkia k. Future Med Chem. 2012 May;4(7):845-52. doi: 10.4155/fmc.12.49. Future Med Chem. 2012. PMID: 22571610 Review.

10

An agarose spot chemotaxis assay for chemokine receptor antagonists.

Vinader V, Al-Saraireh Y, Wiggins HL, Rappoport JZ, Shnyder SD, Patterson LH, Afarinkia K. Vinader V, et al. Among authors: afarinkia k. J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):213-6. doi: 10.1016/j.vascn.2011.01.004. Epub 2011 Feb 1. J Pharmacol Toxicol Methods. 2011. PMID: 21292017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page